Band-Aid Maker Kenvue Cuts Workforce By 4%, Q1 Earnings Beat Street Expectations
Band-Aid Maker Kenvue Cuts Workforce By 4%, Q1 Earnings Beat Street Expectations
Pure-play consumer health company Kenvue Inc (NYSE:KVUE) reported first-quarter sales of $3.89 billion, beating the consensus of $3.79 billion.
Pure-Play消費者健康公司Kenvue Inc（紐約證券交易所代碼：KVUE）報告稱，第一季度銷售額爲38.9億美元，超過市場預期的37.9億美元。
Kenvue's some of the iconic brands include Aveeno, BAND-AID Brand, Johnson's, Listerine, Neutrogena, and Tylenol.
Kenvue的一些標誌性品牌包括Aveeno、BAND-AID Brand、強生、利斯特林、露得清和泰諾。
Sales increased 1.1%, up from 7.3% in the prior year period. Organic growth was 1.9%, up from 11.2% in the prior year.
銷售額增長了1.1％，高於去年同期的7.3％。有機增長率爲1.9％，高於去年的11.2％。
Increases in net sales and organic growth were primarily driven by sustained momentum in Self Care on strong consumer demand and growth in Essential Health led by Oral Care, partially offset by underperformance in Skin Health and Beauty.
淨銷售額的增長和有機增長主要是由強勁的消費者需求和以口腔護理爲首的Essential Health的持續增長推動的Self Care的持續增長勢頭，但皮膚健康與美容的表現不佳部分抵消了增長。
Net sales and organic growth comprised +5.0% value realization and (3.1%) volume.
淨銷售額和有機增長包括 +5.0% 的價值實現率和（3.1%）的銷量。
The self-care segment recorded $1.70 billion in net sales, up 3.5% year over year, with the skin health and beauty segment recording a 5% drop in first-quarter net sales to $1.05 billion. Essential Health segment sales increased around 4% to $1.14 billion.
自我保健板塊淨銷售額爲17.0億美元，同比增長3.5％，皮膚健康和美容板塊第一季度淨銷售額下降5％，至10.5億美元。基本健康板塊的銷售額增長了約4％，達到11.4億美元。
The company reported adjusted EPS of $0.28, down from $0.37 a year ago, beating the consensus of $0.26.
該公司報告調整後的每股收益爲0.28美元，低於去年同期的0.37美元，超過了市場預期的0.26美元。
Kenvue will reduce its current global workforce by approximately 4% and targets annualized pre-tax gross cost savings of approximately $350 million by 2026.
Kenvue將裁減其目前的全球員工隊伍約4％，目標是到2026年每年節省約3.5億美元的稅前總成本。
The company expects to incur approximately $275 million of pre-tax restructuring costs in fiscal year 2024 and fiscal year 2025.
該公司預計在2024財年和2025財年將產生約2.75億美元的稅前重組成本。
The first quarter adjusted gross profit margin was 60.2% vs. 57.3% in the prior year. Margin expansion of 290 basis points was primarily driven by value realization, continued global supply chain efficiency initiatives, and easing net input cost inflation.
第一季度調整後的毛利率爲60.2％，去年同期爲57.3％。290個點子的利潤增長主要是由價值實現、持續的全球供應鏈效率舉措以及淨投入成本通脹的緩解所推動的。
The adjusted operating income margin was 22.0% vs. 21.3% in the prior year.
調整後的營業收入利潤率爲22.0％，去年同期爲21.3％。
Guidance: Kenvue expects full-year 2024 reported net sales growth of 1.0%- 3.0%, with organic growth of 2.0% to 4.0%.
指導方針：Kenvue預計，2024年全年報告的淨銷售額增長1.0％至3.0％，有機增長2.0％至4.0％。
Kenvue expects full-year 2024 adjusted EPS of $1.10-$1.20 versus consensus of $1.15.
Kenvue預計，2024年全年調整後的每股收益爲1.10美元至1.20美元，而市場普遍預期爲1.15美元。
Price Action: KVUE shares are up 4.95% at $20.03 at last check Tuesday.
價格走勢：在週二的最後一次檢查中，KVUE股價上漲4.95％，至20.03美元。
Photo by Colleen Michaels via Shutterstock
照片由 Colleen Michaels 通過 Shutterstock 拍攝